The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV. The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland Technology Development Corporation (TEDCO) that supports the commercialization of academic-based research in the State of Maryland and thereby supports the State’s efforts to foster economic development. The MII program is a collaboration between the State of Maryland and five Maryland Institutions: University of Maryland, Baltimore, University of Maryland, College Park, Morgan State University, University of Maryland Baltimore County, and Johns Hopkins University.
Johns Hopkins University moved up to 13th in the world and ninth among U.S. universities in the newest Times Higher Education world university rankings, published Tuesday.
BioHealth Innovation CEO, Richard Bendis discusses with Montgomery County Economic Development Corporation for #MOCO365 how BioHealth Innovation helps accelerate the growth of life science and biohealth companies.
Five startups have been selected to participate in the inaugural M-1 Ventures health and fitness-focused accelerator program based at Johns Hopkins University.
MdBio Foundation is excited to be partnering with Verizon Innovative Learning to bring a new mobile experience to District of Columbia Public Schools. The Verizon Innovative Learning explorer lab is an entirely new way for middle school students to discover concepts of engineering design. The explorer lab is a shared immersive learning experience that combines movie-quality video, special effects, and hands-on educational gaming to create a learning environment that gets kids excited about science, technology, engineering and math (STEM) – right in the school parking lot.
Universities often seek to supplement their coffers by finding ways to access private-sector funds, such as by setting up technology transfer offices and trying to commercialise their research.
Wednesday, October 18 – Friday, October 20, 2017 at the MC Bioscience Education Center in Germantown, MD.
Bio-Trac® Training Programs is currently accepting preregistrations for our 2017 hands-on training workshops. Preregistration is strongly encouraged due to our small class sizes. Simply provide the few required details below and indicate applicable course(s). We will contact you directly with complete details upon receipt of your preregistration.
Join BioBuzz and sponsor BIOTrain for our next networking event and showcase of the continuing-education and workforce support programs throughout the county and state.
There also will be a tour of Montgomery College’s state-of-the-art labs in the same building around 6pm.
TEDCO’s 7th Annual Entrepreneur Expo will bring together all of Maryland’s entrepreneurial resources from across the state into one place, at one time.
You can expect to see 700+ of the region’s top entrepreneurs, small and large business executives, angel and venture capital investors, federal and state economic development officials, university leaders and legislators.
Already dubbed a ‘tech hub’, the Baltimore-Washington region has built a solid foundation in cyber activities as they pertain to government agencies and defense contracting. Now a transformation is underway to build up the commercial side of cyber. And that’s precisely what this panel will reinforce.
Women of the Virginia bioscience community from across the state will lead this full day event offering examples of working together to build a stronger bioscience industry, stronger companies and institutions, stronger teams and networks, and stronger individuals.
The Maryland Department of Commerce invites you to learn about the new Maryland Defense Diversification Assistance Program that is designed to assist Maryland companies with dependence on US Department of Defense contracts to expand into international markets. The presentation will highlight Australia (particularly the State of Victoria) as a destination for exporting and partnerships.
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is pleased to announce the 12 finalists selected to pitch their pediatric medical device innovation at our 5th Annual Pediatric Device Innovation Symposium on Sunday, September 24th in San Jose, CA.
Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for treating cancers.
Can genomics wizards make an informed guesstimate on what a person looks like, based on his or her DNA? J. Craig Venter sure thinks so, per a new PNAS paper. Yet his Human Longevity Institute study is facing Twitter blowback for that claim.
Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) in San Diego, California have devised a way to optically image tumors with unprecedented clarity using quantum dots. These nano structures are tiny particles, only a few nanometers wide, that generate light of a specific wavelength when they’re themselves stimulated by a light beam. On their own quantum dots are quite bright, but their signal gets washed out by other nearby quantum dots. To clean the signal and be able to see tumors better, the SBP team used a so-called “etchant”.
Do you have experience in digital health? Are you passionate about developing innovative solutions to complex challenges? If so, consider joining the FDA Digital Health team as an Entrepreneur-in-Residence! The Center for Devices and Radiological Health (CDRH) is establishing this Entrepreneur-in-Residence (EIR) Program to support and help develop our Software Precertification (PreCert) Pilot Program —a critical piece of our Digital Health Innovation Action Plan, announced on August 8, 2017.
It was an audacious undertaking, even for one of the most storied American companies: With a single machine, IBM would tackle humanity’s most vexing diseases and revolutionize medicine.
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
